These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9598425)

  • 41. The significance of differences between means. A simulation study.
    McArdle BH
    Comp Biochem Physiol A Comp Physiol; 1987; 87(4):979-82. PubMed ID: 2887396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. More on the means comparison with unequal variances problem.
    Ames MH
    J Biopharm Stat; 1996 May; 6(2):177-83. PubMed ID: 8732912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A simple hybrid variance estimator for the Kaplan-Meier survival function.
    Borkowf CB
    Stat Med; 2005 Mar; 24(6):827-51. PubMed ID: 15558837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishing bioequivalence in complete and incomplete data designs using AUCs.
    Jaki T; Wolfsegger MJ; Lawo JP
    J Biopharm Stat; 2010 Jul; 20(4):803-20. PubMed ID: 20496207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Profile likelihood-based confidence intervals using Monte Carlo integration for population pharmacokinetic parameters.
    Funatogawa T; Funatogawa I; Yafune A
    J Biopharm Stat; 2006; 16(2):193-205. PubMed ID: 16584067
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug-drug interaction prediction: a Bayesian meta-analysis approach.
    Li L; Yu M; Chin R; Lucksiri A; Flockhart DA; Hall SD
    Stat Med; 2007 Sep; 26(20):3700-21. PubMed ID: 17357990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estimation of confidence intervals for area under the curve from destructively obtained pharmacokinetic data.
    Gagnon RC; Peterson JJ
    J Pharmacokinet Biopharm; 1998 Feb; 26(1):87-102. PubMed ID: 9773394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimation of the concordance correlation coefficient for repeated measures using SAS and R.
    Carrasco JL; Phillips BR; Puig-Martinez J; King TS; Chinchilli VM
    Comput Methods Programs Biomed; 2013 Mar; 109(3):293-304. PubMed ID: 23031487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Higher-moment approaches to approximate interval estimation for a certain intraclass correlation coefficient.
    Zou KH; McDermott MP
    Stat Med; 1999 Aug; 18(15):2051-61. PubMed ID: 10440886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Applying Bailer's method for AUC confidence intervals to sparse sampling.
    Nedelman JR; Gibiansky E; Lau DT
    Pharm Res; 1995 Jan; 12(1):124-8. PubMed ID: 7724473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A note on testing areas under the curve when using destructive measurement techniques.
    Heinzl H
    J Pharmacokinet Biopharm; 1996 Dec; 24(6):651-5. PubMed ID: 9300355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On using an approximate noncentral t-distribution in determining a one-side upper limit for future sample relative reproducibility standard deviations.
    McClure FD; Lee JK
    J AOAC Int; 2007; 90(2):575-81. PubMed ID: 17474527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimation of AUC from 0 to Infinity in Serial Sacrifice Designs.
    Wolfsegger MJ; Jaki T
    J Pharmacokinet Pharmacodyn; 2005 Dec; 32(5-6):757-66. PubMed ID: 16328101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solutions to the Behrens-Fisher problem.
    Reed JF
    Comput Methods Programs Biomed; 2003 Mar; 70(3):259-63. PubMed ID: 12581558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statistical comparison of dissolution curves.
    Bartoszynski R; Powers JD; Herderick EE; Pultz JA
    Pharmacol Res; 2001 Apr; 43(4):369-87. PubMed ID: 11352542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of interval estimations in design and evaluation of multiregional clinical trials with continuous outcomes.
    Chiang C; Hsiao CF
    Stat Methods Med Res; 2019 Jul; 28(7):2179-2195. PubMed ID: 29355082
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Construction of an optimal destructive sampling design for noncompartmental AUC estimation.
    Vandenhende F; Comblain M; Delsemme MH; Dewe W; Hoffman WP; Boulanger B
    J Pharmacokinet Biopharm; 1999 Apr; 27(2):191-212. PubMed ID: 10567955
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of methods for estimating individual pharmacokinetic parameters.
    Amisaki T; Eguchi S
    J Pharmacokinet Biopharm; 1999 Feb; 27(1):103-21. PubMed ID: 10533700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exact 95% confidence intervals for differences in binomial proportions.
    Fagan T
    Comput Biol Med; 1999 Jan; 29(1):83-7. PubMed ID: 10207656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A COMPARISON OF POWER APPROXIMATIONS FOR SATTERTHWAITE'S TEST.
    Disantostefano RL; Muller KE
    Commun Stat Simul Comput; 1995; 24(3):583-593. PubMed ID: 24078764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.